Sandoz Says Feds Misclassified Generics As 'Innovator Drugs'

By Henrik Nilsson · April 11, 2024, 10:47 PM EDT

Pharmaceutical company Sandoz Inc. sued the Centers for Medicare & Medicaid Services in Washington, D.C., federal court on Wednesday, alleging the agency ignored the company's objection to classifying two of its generics...

To view the full article, register now.